Fellow

No ORCID on file · 1 paper in corpus · active 2010

Study types

  • review 1
review 2010
·doi:10.17925/ee.2013.09.01.18

Hormonal therapies such as progestins have only modest activity in the treatment of advanced endometrial cancer. Mechanisms of resistance to progestin therapy are not well understood. However, activation of the PI3K/AKT/mammalian target of …